benralizumab (Fasenra) Last Updated: December 21, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: benralizumab Indications: Asthma, severe eosinophilic Brand Name: FasenraManufacturer: AstraZeneca Canada Inc.Project Number: SF0592-000Project Status: ActiveSubmission Type: RequestForAdvice Tags Asthma, Asthma, Respiratory Details
mepolizumab (Nucala) Last Updated: December 21, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: mepolizumab Indications: Asthma, severe eosinophilic Brand Name: NucalaManufacturer: GlaxoSmithKline Inc.Project Number: SF0593-000Project Status: ActiveSubmission Type: RequestForAdvice Tags Asthma, Asthma, Respiratory Details
reslizumab (Cinqair) Last Updated: December 21, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: reslizumab Indications: Asthma, eosinophilic Brand Name: CinqairManufacturer: TEVA Canada Innovation Project Number: SF0591-000Project Status: ActiveSubmission Type: RequestForAdvice Tags Asthma, Asthma, Respiratory Details
filgrastim (TBC) Last Updated: December 11, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: filgrastim Indications: Prevention or treatment of neutropenia in various indications Brand Name: TBCManufacturer: Pfizer Canada Inc.Project Number: SE0585-000Project Status: ActiveSubmission Type: New Tags Blood, Cancer, Pediatrics, Blood, Cancer, HIV/AIDS, Pediatrics Details
edaravone (Radicava) Last Updated: February 14, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: edaravone Indications: amyotrophic lateral sclerosis Brand Name: RadicavaManufacturer: Mitsubishi Tanabe Pharma CorporationProject Number: SR0573-000 Project Status: ActiveSubmission Type: New Tags Nervous System, Nervous system Details
Bevacizumab (TBD) mCRC NSCLC Biosimilar – Details Published on: February 15, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10178
insulin degludec + liraglutide (Xultophy) Last Updated: February 14, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: insulin degludec + liraglutide Indications: Diabetes mellitus, Type 2 Brand Name: XultophyManufacturer: Novo Nordisk Canada Inc.Project Number: SR0599-000Project Status: ActiveSubmission Type: NewCombination Tags Diabetes Details
risankizumab (TBC) Last Updated: December 13, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: risankizumab Indications: Psoriasis, moderate to severe plaque Brand Name: TBCManufacturer: AbbVie CorporationProject Number: SR0583-000Project Status: ActiveSubmission Type: New Tags Dermatology, Dermatology Details
isavuconazole (Cresemba) Last Updated: December 21, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: isavuconazole Indications: Treatment of invasive aspergillosis and mucormycosis Brand Name: CresembaManufacturer: AVIR Pharma Inc.Project Number: SR0586-000 Project Status: ActiveSubmission Type: New Tags Infectious Diseases, Nervous System, Infectious diseases, Nervous system, Respiratory, isavuconazole; isavuconazonium sulfate; isavuconazonium sulphate Details
cerliponase alfa (Brineura) Last Updated: December 21, 2018 Result type: Reports Product Line: Common Drug Review Generic Name: cerliponase alfa Indications: Neuronal Ceroid Lipofuscinosis Type 2 Brand Name: BrineuraManufacturer: Biomarin Pharmaceutical (Canada) Inc.Project Number: SR0574-000Project Status: ActiveSubmission Type: New Tags Genetics, Nervous System, Lipid Metabolism Disorders, Genetics, Nervous system, neuronal ceroid lipofuscinosis; neuronal ceroid lipofuscinoses; ceroid storage disease; Batten disease; cln2; Batten diseases; ceroid storage diseases; brineura; cerliponase alfa; cerliponase alpha Details
